LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 140 pages found matching zyprexa- Diabetes y aumento de peso por Zyprexa
Zyprexa (olanzapina) es un medicamento recetado para el tratamiento de la esquizofrenia y la manía bipolar y se lo ha vinculado a la diabetes mellitus, la hiperglucemia, la pancreatitis y a trastornos de azúcar en sangre. Se han informado 288 casos de diabetes en pacientes a los que se administró Zyprexa; 23 de ellos resultaron fatales... - Zyprexa Lawsuits - Eli Lilly May Lose Insurance Coverage
Aug-3-06 In the company's first quarter report for 2006, Eli Lilly says it is having problems with insurance coverage. "We have experienced difficulties in obtaining product liability insurance due to a very restrictive insurance market," the report says, "and therefore will be largely self-insured for future product liability losses." Although Lilly has cover... - Zyprexa Diabetes and Weight Gain
Zyprexa ( olanzapine ), prescribed for the treatment of schizophrenia and bipolar mania, has been linked to serious side effects. These Zyprexa side effects reportedly include diabetes mellitus, hyperglycemia, pancreatitis and increased risk of suicide. According to some lawsuits, Eli Lilly, maker of Zyprexa, allegedly knew about the link between Zypr... - Lilly Receives Zyprexa Greetings From Capitol Hill
Apr-27-07 Washington, DC: The Chairman and CEO of Eli Lilly, Sidney Taurel, has become a regular pen pal with lawmakers on Capitol Hill since the company's ten-year campaign to increase profits by promoting the off-label use of Zyprexa for patients covered by public health care programs became the focus of investigations in both houses of Congress. According... - Zyprexa Sales Show No Amount of Lawsuits Will Deter Lilly
Sep-28-06 Indianapolis, IN Scores of new lawsuits are being filed by patients who say they took Zyprexa without knowing the risks after Eli Lilly promoted the drug to doctors as a treatment for conditions other than schizophrenia and bipolar disorder that the drug is approved to treat. In June 2005, Lilly announced plans to settle roughly 8,000 claims by pati... - Public has Right to know Secrets revealed in Zyprexa Documents
Jan-15-07 Washington, DC In deciding whether to allow Eli Lilly to continue to use court orders to hide documents that show the company illegally marketed Zyprexa for unapproved uses and failed to warn the public about the serious health risks associated with the drug for a decade, the court needs to consider the harm done to the public by Lilly's conduct. Th... - Zyprexa Medicaid Gravy Train Derailed
Feb-20-06 When Zyprexa was approved to treat adults with schizophrenia in 1996, Eli Lilly and the FDA knew about the drug's lethal side effects. Data from a 1996 six-week clinical trial revealed 27 deaths, 15 of which were suicides, and a drop-out rate of 65%. In his book, Mad In America, investigative journalist Robert Whitaker, reported that one in every 145... - Drug Companies Still Peddling Risperdal and Zyprexa For Off-Label Use
Jun-17-06 According to Kelly O'Meara, author of the newly released book, Psyched Out, America has a drug problem. "It's not as covert as those illicit and illegal "Just Say No" drugs," she says, "but, rather, Americans have become drug users by way of being diagnosed as suffering from one or a number of alleged mental disorders." "Sharing one's feelings with a doc... - Zyprexa and Suicidal Behavior
Zyprexa is used to treat symptoms of schizophrenia and acute bipolar mania. However, Zyprexa has been linked to serious side effects. Reported Zyprexa side effects include an increased risk of suicide, diabetes and stroke. The alleged link between Zyprexa and suicide has been the focus of lawsuits filed against Eli Lilly, maker of Zyprexa. Zy... - Attorney Subpoenas J&J, AstraZeneca and Lilly for Hidden Antipsychotic Data Part I
Sep-10-07 Washington, DC Alaska attorney Jim Gottstein has issued subpoenas for the discovery of any suppressed data on the atypical antipsychotic drugs Zyprexa , Risperdal, and Seroquel which he says is necessary before a Forced Drugging Petition can possibly be considered for approval for a client he is representing. Mr Gottstein contends that the informatio... - Lilly's Worst Zyprexa Nightmare comes True
May-7-07 Washington, DC: Eli Lilly is not all that worried about personal injury lawsuits related to Zyprexa because the company has enough money to pay the relatively small pay-outs that arise from such actions, according to Attorney Barry Turner, a professor of law and ethics in the UK and a leading authority on consumer fraud litigation involving the pharmac... - Zyprexa Hole Gets Deeper
May-1-07 Washington, DC: On March 7, 2007, Montana's attorney general, Mike McGrath, filed the latest Medicaid fraud lawsuit against Eli Lilly, under the False Claims Act, for illegally promoting the sale of the atypical antipsychotic drug Zyprexa for off-label uses and concealing its link to serious health problems. Considered to be one of the most effecti... - Court Allows Eli Lilly to Bury Zyprexa Documents
Dec-21-06 New York, NY Alaskan attorney, Jim Gottstein, says that after being served with a mandatory injunction, he has returned the internal Eli Lilly documents that he obtained in litigation and provided to the New York Times to the court. Information from the documents related to Lilly's antipsychotic drug, Zyprexa , was highlighted two days in a row in fr... - Zyprexa Side Effects are Deadly
Nov-21-07 St. Petersburg, FL There appears to be no group that is safe from the deadly side effects of Zyprexa . Seniors with dementia who are given the drug are at an increased risk of death, adults and children have a risk of suicidal tendencies and those who survive that may suffer from serious weight gain and diabetes. With all these potentially dangerous sid... - Lilly Faces Mounting Legal Battles Over Zyprexa - Part II
Nov-10-07 Washington, DC: Several Zyprexa -related class actions have been filed against Eli Lilly on behalf of the company's shareholders charging Lilly, and certain of its officers and directors, with violations of the Securities Exchange Act. On April 2, 2007, the Schiffrin Barroway Topaz & Kessler law firm issued a press release to announce a class act... - Attorney Subpoenas J&J AstraZeneca and Lilly for Hidden Antipsychotic Data Part II
Sep-10-07 Washington, DC Attorney Jim Gottstein is the director of the Law Project for Psychiatric Rights, a public interest law firm that has mounted a campaign against forced psychiatric drugging all over the country. He represents mostly indigent clients through his non-profit organization and is not involved in the lawsuits filed against the atypical makers by p... - Activists Take on Eli Lilly Over Off-Label Sale of Zyprexa
Feb-27-07 Washington, DC: On February 23, 2007, a new grass roots advocacy group issued a press release to rally support for attorney, Jim Gottstein, in his legal battle with Eli Lilly over his role in providing secret company documents obtained in litigation to the media to alert the public about the health risks associated with Zyprexa that were kept hidden si... - Zyprexa Injury Clock Keeps Ticking Away
Feb-2-07 San Jose, CA The on-going legal battle over the disclosure of secret Eli Lilly documents that reveal the serious health risks associated with Zyprexa and the company's off-label promotion of the drug involves a matter of grave public concern. But observers on the sidelines of this courtroom circus say the conduct of the judge in helping Lilly keep d... - Eli Lilly Set to Accept $1.4 Billion Whistleblower Settlement
Jan-18-09 Washington, DC To say that a whistleblower cost a major pharmaceutical company $1.4 billion detracts from the value of whistle blowing as a major support protecting the safety and interests of consumers. How else might we have known about the alleged wrongdoings of Big Pharma giant Eli Lilly with regard to the marketing of Zyprexa? Whistleblowers perform... - Lilly Faces Mounting Legal Battles Over Zyprexa - Part I
Nov-8-07 Washington, DC: Since August 2006, as part of an on-going, multistate investigative effort by approximately 30 states, Eli Lilly has received civil investigative demands or subpoenas seeking a broad range of documents relating to the company's marketing and promotion of the antipsychotic drug Zyprexa , and more states are expected to join the effort. ...